Chapter 20 Recent considerations in the etiopathogenesis of ALS

Supplements to Clinical Neurophysiology

Volumn 57, Issue C, 2004, Pages 187-190

  Eisen, Andrew ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; MODELS, MOLECULAR; SUPEROXIDE DISMUTASE;

EID: 25144511412     PISSN: 1567424X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-424X(09)70356-3     Document Type: Article

References (24)

1. Agar J., and Durham H. Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. 4 (2003) 232-242
2. Andersen P.M. Genetics of amyotrophic lateral sclerosis. Zh. Nevrol. Psikhiatr. Im. S.S. Korsakova 101 (2001) 54-63
3. Andersen P.M. Genetics of sporadic ALS. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. 2 Suppl. 1 (2001) S37-S41
4. Andersen P.M., Sims K.B., Xin W.W., Kiely R., O'Neill G., Ravits J., Pioro E., Harati Y., Brower R.D., Levine J.S., Heinicke H.U., Seltzer W., Boss M., and Brown Jr. R.H. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. 4 (2003) 62-73
5. Angelov D.N., Waibel S., Guntinas-Lichius O., Lenzen M., Neiss W.F., Tomov T.L., Yoles E., Kipnis J., Schori H., Reuter A., Ludolph A., and Schwartz M. Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 100 (2003) 4790-4795
6. Berke S.J., and Paulson H.L. Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Curr. Opin. Genet. Dev. 13 (2003) 253-261
7. Cleveland J.L. A new piece of the ALS puzzle. Nat. Genet. 34 (2003) 357-358
8. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., and Roos R.P. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261 (1993) 1047-1051
9. Drachman D.B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S., and Rothstein J.D. Cycloox-ygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 52 (2002) 771-778
10. Figlewicz D.A., and Orrell R.W. The genetics of motor neuron diseases. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. 4 (2003) 225-231
11. Hall E.D., Oostveen J.A., and Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23 (1998) 249-256
12. Hyun D.H., Lee M., Halliwell B., and Jenner P. Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J. Neurochem. 86 (2003) 363-373
13. Maihofner C., Probst-Cousin S., Bergmann M., Neuhuber W., Neundorfer B., and Heuss D. Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis. Eur. J. Neurosci. 18 (2003) 1527-1534
14. McGeer P.L., and McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26 (2002) 459-470
15. Ruddy D.M., Parton M.J., Al Chalabi A., Lewis C.M., Vance C., Smith B.N., Leigh P.N., Powell J.F., Siddique T., Meyjes E.P., Baas J.V.F., and De Shaw C.E. Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am. J. Hum. Genet. 73 (2003) 390-396
16. Sapp P.C., Hosler B.A., McKenna-Yasek D., Chin W., Gann A., Genise H., Gorenstein J., Huang M., Sailer W., Scheffler M., Valesky M., Haines J.L., Pericak-Vance M., Siddique T., Horvitz H.R., and Brown Jr. R.H. Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am. J. Hum. Genet. 73 (2003) 397-403
17. Schwartz M. Autoimmunity as the body's defense mechanism against the enemy within: Development of therapeutic vaccines for neurodegenerative disorders. J. Neurovirol. 8 (2002) 480-485
18. Schwartz M., Shaked I., Fisher J., Mizrahi T., and Schori H. Protective autoimmunity against the enemy within: fighting glutamate toxicity. Trends Neurosci. 26 (2003) 297-302
19. Shastry B.S. Neurodegenerative disorders of protein aggregation. Neurochem. Int. 43 (2003) 1-7
20. Simpson E.P., Yen A.A., and Appel S.H. Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr. Opin. Rheumatol. 15 (2003) 730-736
21. Strong M., and Rosenfeld J. Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. 4 (2003) 136-143
22. Taylor J.P., Hardy J., and Fischbeck K.H. Toxic proteins in neurodegenerative disease. Science 296 (2002) 1991-1995
23. Urushitani M., Kurisu J., Tsukita K., and Takahashi R. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J. Neurochem. 83 (2002) 1030-1042
24. Valentine J.S., and Hart P.J. Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 100 (2003) 3617-3622